Synopsis of recent research by authors named "Cui-Yu Sun"
Research by Cui-Yu Sun focuses on the mechanisms underlying metabolic regulation, specifically exploring the synergistic effects of fibroblast growth factor-21 (FGF-21) and insulin on glucose metabolism.
Another area of his research investigates potential therapeutic solutions for rheumatoid arthritis, particularly through the development and testing of bispecific antibodies targeting specific interleukins.
His findings indicate that FGF-21 can improve insulin sensitivity, and among the bispecific antibodies tested, BsAB-1 demonstrated the most effective binding and potential therapeutic benefits in rheumatoid arthritis models.
